The reduction in the circulatory glucose concentration, together with the hormonal changes, results in mobilization of lipid storage [24]
If effectiveness does not improve, discuss dose adjustment with your provider
Whenever possible, this should be discouraged
SELECT Trial Cardiovascular Disease 20% reduction in the risk of cardiovascular events 37% risk reduction in a broader set of secondary outcomes (including cardiovascular death and stroke) FLOW Trial Chronic Kidney Disease: Novo Nordisks clinical trial , which enrolled 3,533 people with type 2 diabetes and CKD, was ended early as a result of clear efficacy
It allows you to focus on the science, confident that your materials won't be a confounding variable
Spending time eating instead of rushing gives your gut a chance to send satiety signals properly